Inhibition of HT-29 Human Colon Cancer Growth under the Renal Capsule of Severe Combined Immunodeficient Mice by an Analogue of 1,25-Dihydroxyvitamin D3, DD-003

Cancer Research

Volumn 54, Issue 19, 1994, Pages 5148-5153

  Kawai, Makoto ^c   Iseki, Katsuhiko ^b   Ikekawa, Nobuo ^a  

^a STRATTON VA MEDICAL CENTER   (United States)

^b MEC Laboratory   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

26,26,26,27,27,27 HEXAFLUORO 1ALPHA,22,25 TRIHYDROXY 24 HOMOCOLECALCIFEROL; CALCITRIOL; CALCITRIOL DERIVATIVE; CALCIUM; DD 003; FIBRINOGEN; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; COLON CANCER; COLON SURGERY; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FIBRIN CLOT; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCITRIOL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MICE; MICE, SCID; RECEPTORS, CALCITRIOL; SUBRENAL CAPSULE ASSAY; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0028019402     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Garland, C. F. Shekelle, R. B. Barrett-Connor, E. Crioui, M. H. Rossof, A. H. and Paul, O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet, 1: 307-309, 1985.
2. Garland, C. F. Comstock, G. W. Garland, F. C. Helsing, K. J. Shaw, E. K. and Gorham, E. D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet, 2: 1176-1178, 1989.
3. Pence, B. C. and Buddingh, F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis (Lond.), 9: 187-190, 1988.
4. Smith, E. L. Walworth, N. D. and Holick, M. F. Effect of 1,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum free conditions. J. Invest. Dermatol. 86: 709-714, 1986.
5. Miyaura, C. Abe, E. Kuribayashi, T. Tanaka, H. Konno, H. Nishii, Y. and Suda, T. 1,25-Dihydroxyvitamin D3 induced differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun. 102: 937-943, 1981.
6. Tanaka, Y. Bush, K. K. Klauck, T. M. and Higgins, P. J. Enhancement of butyrate-induced differentiation of HT-29 human colon carcinoma cells by 1,25-dihydroxyvitamin D3. Biochem. Pharmacol. 38: 3859-3865, 1989.
7. Eisman, J. A. Barkla, D. H. and Tutton, J. M. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res. 47: 21-25, 1987.
8. Belleli, A. Shany, S. Levy, J. Guberman, R. and Lamprecht, S. A. A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis. Carcinogenesis (Lond.), 73: 2293-2298, 1992.
9. Ikekawa, N. Stereochemistry and physiological significance of hydroxylation of vitamin D side-chain. Bioorg. Med. Chem. Lett. 3: 1789-1794, 1993.
10. Norman, A. W. Zhou, J. Y. Henry, H. L. Uskokovic, M. R. and Koeffler, H. P. Structure-function studies on analogues of 1,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res. 50: 6857-6864, 1990.
11. Abe, J. Nakano, T. Nishii, Y. Matsumoto, T. Ogata, E. and Ikeda, K. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology, 729: 832-837, 1991.
12. Colson, K. W. MacKay, A. G. James, S. Y. Binderup, L. Chander, S. and Coombes, R. C. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem. Pharmacol. 44: 2273-2280, 1992.
13. Iseki, K. Nagai, T. Tanaka, Y. Kawai, M. Ikekawa N. and Kobayashi, Y. Structure-activity studies of fluorinated vitamin D analogs. In: A. W. Norman (ed.), Proceedings of the Ninth Workshop of Vitamin D. New York: Walter de Gruyter & Co. in press, 1994.
14. Iseki, K. Nagai, T. and Kobayashi, Y. Synthesis of 24-homo-26,26,26,27,27,27-hexafluoro-l,22,25-trihydroxyvitamin D3. Chem. Pharm. Bull. (Tokyo), 40: 1346-1348, 1992.
15. Carmichael, J. DeGraff, W. G. Gazdar, A. F. Minna, J. D. and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47: 936-942, 1987.
16. Fingert, H. J. Chen, Z. Mizrahi, N. Gajewski, W. H. Bamberg, M. P. and Kradin, R. L. Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assay. Cancer Res. 47: 3824-3829, 1987.
17. Tanaka, Y. Bush, K. K. Eguchi, T. Ikekawa, N. Taguchi, T. Kobayashi, Y. and Higgins, P. J. Effects of 1,25-dihydroxyvitamin D3 and its analogs on butyrate-induced differentiation of HT-29 human colon carcinoma cells and on the reversal of the differentiated phenotype. Arch. Biochem. Biophys. 276: 415-423, 1990.
18. Brehier, A. and Thomasset, M. Human colon cell line HT-29: characterization of 1,25-dihydroxyvitamin D3 receptor and induction of differentiation by the hormone. J. Steroid Biochem. 29: 265-270, 1988.
19. Zhao, X. and Feldman, D. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology, 132: 1808-1814, 1993.
20. Harper, K. D. Lozzo, R. V. and Haddad, J. G. Receptor for and bioresponse to 1,25-dihydroxyvitamin D in a human colon carcinoma cell line (HT-29). Metabolism, 38: 1062-1069, 1989.
21. Godyn, J. J. Xu, H. Zhang, F. Kolla, S. and Studzinski, G. P. A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D3. Cell Proliferation, 27: 37-46, 1994.
22. Oikawa, T. Hirotani, K. Ogasawara, H. Katayama, T. Nakamura, O. Iwaguchi, T. and Hiragun, A. Inhibition of angiogenesis by vitamin D3 analogues. Eur. J. Pharmacol. 77: 247-250, 1990.
23. Majewski, S. Szmurlo, A. Marczak, M. Jablonska, S. and Bollag, W. Inhibition of tumor cell-induced angiogenesis by retinoids, 1,25-dihydroxyvitamin D3 and their combination. Cancer Lett. 75: 35-39, 1993.
24. Augeron, G. and Laboisse, C. L. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res. 44: 3961-3969, 1984.
25. Hekmati, M. Polak-Charcon, S. and Ben-Shaul, Y. A morphological study of human adenocarcinoma cell line (HT- 29) differentiating in culture. Similarities to intestinal embryonic development. Cell Differ. Dev. 31: 207-218, 1990.
26. Tanaka, Y. DeLuca, H. F. Kobayashi, Y. and Ikekawa, N. 26,26,26,27,27,27-Hexafluoro- 1,25-dihydroxyvitamin D3: a highly potent and long-lasting analog of 1,25-dihydroxyvitamin D3. Arch. Biochem. Biophys. 229: 348-354, 1984.
27. Ostrem, V. K. Tanaka, Y. Prahl, J. DeLuca, H. F. and Ikekawa, N. 24- and 26-homo-1,25-dihydroxyvitamin D3: preferential activity inducing differentiation of human leukemia cells HL-60 in vitro. Proc. Natl. Acad. Sci. USA, 84: 2610-2614, 1987.
28. Eguchi, T. Yoshida, M. and Ikekawa, N. Synthesis and biological activities of 22-hydroxy and 22-methoxy derivatives of 1,25-dihydroxyvitamin D3: importance of side chain conformation for biological activities. Bioorg. Chem. 17: 294-307,1989.
29. DeLuca, H. F. Krisinger, J. and Darwish, H. The vitamin D system: 1990. Kidney Int. 38, Suppl. 29: S2-S8, 1990.
30. DeBoland, A. R. and Norman, A. W. Evidence for involvement of protein kinase C and cyclic adenosine 3’,5’ monophosphate-dependent protein kinase in the 1,25-dihydroxyvitamin D3-mediated rapid stimulation of intestinal calcium transport (Transcalcachia). Endocrinology, 727: 39-45, 1990.
31. Inaba, M. Okuno, S. Nishizawa, Y. Imanishi, Y. Katsumata, T. Sugata, I. and Morii, H. Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3. Biochem. Pharmacol. 45: 2331-2336, 1993.
32. Bouillon, R. Allewaert, K. Xiang, D. Z. Tan, B. K. and Baelen, H. V. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity. J. Bone Miner. Res. 6: 1051-1057, 1991.
33. Black, M. M. and Speer, F. D. Further observations on the effects of cancer chemotherapeutic agents in the in vitro dehydrogenase activity of cancer tissue. J. Nad. Cancer Inst. 14: 1147-1158, 1954.
34. Anai, H. Maehara, Y. Kusumoto, H. and Sugimachi, K. Comparison between succinate dehydrogenase inhibition test and subrenal capsule assay for chemosensitivity testing. Oncology, 44: 115-117, 1987.
35. Jacobson, H. I. Bennett, J. A. and Mizejewski G. J. Inhibition of estrogen-dependent breast cancer growth by a reaction product of α-fetoprotein and estradiol. Cancer Res. 50: 415-420, 1990.
36. Tanaka, Y. Frank, H. and DeLuca, H. F. Role of 1,25- dihydroxycholecalciferol in calcification of bone and maintenance of serum calcium concentration in the rat. J. Nutr. 702: 1569-1578, 1972.
37. Bosma, G. C. Custer, R. P. and Bosma, M. J. A severe combined immunodeficiency mutation in mice. Nature (Lond.), 301: 527-530, 1983.
38. Mueller, B. M. and Reisfeld, R. A. Potential of the SCID mouse as a host for human tumors. Cancer Metastasis Rev. 10: 193-200, 1991.
39. Williams, S. S. Alosco, T. R. Cray, B. A. and Bankert, R. B. The study of human neoplastic disease in severe combined immunodeficient mice. Lab. Anim. Sci. 43: 139-146, 1993.
40. Sands, H. Jones, P. J. Neacy, W. Shah, S. A. and Gallagher, B. M. The imaging of small experimental murine tumors grown in the subrenal capsule using monoclonal antibodies. Cancer Lett. 24: 65-72, 1984.
41. Bennett, J. A. Pilon, V. A. and MacDowell, T. Evaluation of growth and histology of human tumor xenografts implanted under the renal capsule of immunocompetent and immunodeficient mice. Cancer Res. 45: 4963-4969, 1985.
42. Ogino, M. Sakamoto, T. Yamamoto, T. Mori, H. Okinaga, S. and Arai, K. Subrenal capsule assay as a test to predict the effectiveness of chemotherapy in choriocarcinoma. Gynecol. Oncol. 38: 32-36, 1990.
43. Griffin, T. W. Bogden, A. E. Reich, S. D. Antonelli, D. Hunter, R. E. Ward, A. Yu, D. T. Greene, H. L. and Costanza, M. E. Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy. Cancer (Phila.), 52: 2185-2192, 1983.
44. Martin, D. S. Balis, M. E. Fisher, B. et al. Role of murine tumor models in cancer treatment research. Cancer Res. 46: 2189-2192, 1986.